참고문헌 (23)

1. 1 Leibovici L Samra Z Konigsberger H Drucker M Ashkenazi S Pitlik SD Long-term survival following bacteremia or fungemia JAMA 1995 274 807 812 7650804 

   상세보기

2. 2 Pedersen G Schønheyder HC Sørensen HT Source of infection and other factors associated with case fatality in community-acquired bacteremia-a Danish population-based cohort study from 1992 to 1997 Clin Microbiol Infect 2003 9 793 802 14616699 

3. 3 Friedman ND Kaye KS Stout JE Stout JE McGarry SA Trivette SL Briggs JP Lamm W Clark C MacFarquhar J Walton AL Reller LB Sexton DJ Healthcare-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections Ann Intern Med 2002 137 791 797 12435215 

   상세보기

4. 4 Siegman-Igra Y Fourer B Orni-Wasserlauf R Golan Y Noy A Schwartz D Giladi M Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia Clin Infect Dis 2002 34 1431 1439 12015688 

   상세보기

5. 5 Shorr AF Tabak YP Killian AD Gupta V Liu LZ Kollef MH Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database Crit Care Med 2006 34 2588 2595 16915117 

   상세보기

6. 6 Weinstein MP Towns ML Quartey SM Mirrett S Reimer LG Parmigiani G Reller LB The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults Clin Infect Dis 1997 24 584 602 9145732 

   상세보기

7. 7 Lark RL Chenoweth C Saint S Zemencuk JK Lipsky BA Plorde JJ Four year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient outcome Diagn Microbiol Infect Dis 2000 38 131 140 11109010 

   상세보기

8. 8 Lark RL Saint S Chenoweth C Zemencuk JK Lipsky BA Plorde JJ Four-year prospective evaluation of community-acquired bacteremia: epidemiology, microbiology, and patient outcome Diagn Microbiol Infect Dis 2001 41 15 22 11687309 

   상세보기

9. 9 McDonald JR Friedman ND Stout JE Sexton DJ Kaye KS Risk factors for ineffective therapy in patients with bloodstream infection Arch Intern Med 2005 165 308 313 15710794 

   상세보기

10. 10 Rangel-Frausto MS Pittet D Costigan M Hwang T Davis CS Wenzel RP The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study JAMA 1995 273 117 123 7799491 

    상세보기

11. 11 American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit Care Med 1992 20 864 874 1597042 

    상세보기

12. 12 Chow JW Yu VL Combination antibiotic versus monotherapy for gram-negative bacteremia: a commentary Int J Antimicrob Agents 1999 11 7 12 10075272 

13. 13 Kang CI Kim SH Park WB Lee KD Kim HB Kim EC Oh MD Choe KW Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome Antimicrob Agents Chemother 2005 49 760 766 15673761 

    상세보기

14. 14 Kasiakou SK Michalopoulos A Soteriades ES Samonis G Sermaides GJ Falagas ME Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis Antimicrob Agents Chemother 2005 49 3136 3146 16048915 

    상세보기

15. 15 Clinical and Laboratory Standards Institute Document No. M100-S15 Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement 2005 Wayne, PA CLSI 

16. 16 Cheong HS Kang CI Kwon KT Heo ST Wi YM Kim ES Lee JS Ko KS Chung DR Lee NY Song JH Peck KR Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia J Antimicrob Chemother 2007 60 1355 1360 17923453 

    상세보기

17. 17 Kang CI Cheong HS Chung DR Peck KR Song JH Oh MD Choe KW Clinical features and outcome of community-onset bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli Eur J Clin Microbiol Infect Dis 2008 27 85 88 17943331 

18. 18 Lesens O Hansmann Y Brannigan E Hopkins S Meyer P O'Connel B Prévost G Bergin C Christmann D Healthcare-associated Staphylococcus aureus bacteremia and the risk for methicillin resistance: is the Center for Disease Control and Prevention definition for community acquired bacteremia still appropriate? Infect Control Hosp Epidemiol 2005 26 204 209 15756893 

19. 19 Ramphal R Importance of adequate initial antimicrobial therapy Chemotherapy 2005 51 171 176 15980627 

    상세보기

20. 20 Du B Long Y Liu H Chen D Liu D Xu Y Xie X Extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome Intensive Care Med 2002 28 1718 1723 12447513 

    상세보기

21. 21 Elhanan G Sarhat M Raz R Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infection J Infect 1997 35 283 288 9459403 

    상세보기

22. 22 Byl B Clevenbergh P Jacobs F Jacobs F Struelens MJ Zech F Kentos A Thys JP Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia Clin Infect Dis 1999 29 60 66 10433566 

    상세보기

23. 23 Pazos Añón R Fernández Rodríguez R Paz Vidal I Tinajas A Cantón I Abel V González R Martínez R Gayoso P Fernández Alvarez O Prognostic factors of bacteremia: prospective study An Med Interna 2001 18 415 420 11589079